HBIO harvardbioscience.com: Prakiraan wutah bathi saben saham kanggo taun ngarep
Deep robotization of precision instrument assembly at Harvard Bioscience (HBIO) minimizes costs, which is evident when viewing the chart on GURU.Markets: consensus expectations for n+1 profit dynamics demonstrate market demand, where 97.80 characterizes this valuation parameter. Its gold standard status in science makes the equipment indispensable for pharmaceutical laboratories, while a focus on direct sales and asset integration optimizes margins.
Rincian analitis perusahaan Harvard Bioscience
- rega lan prakiraan konsensus rega:
- data kapitalisasi saham perusahaan:
- informasi kapitalisasi buku:
- indikator beban utang lan likuiditas:
Utang marang Ekuitas Harvard Bioscience|HBIO - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Harvard Bioscience, Inc.|HBIO - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Harvard Bioscience|HBIO - Tanggungan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Harvard Bioscience|Likuiditas cepet harvardbioscience.com
- data bathi resik lan rasio valuasi:
HBIO - Asil keuangan resik|Proyeksi bathi mangsa ngarep Harvard Bioscience|HBIO - Nilai perusahaan marang bathi resik|Pangali Forward P/E Harvard Bioscience|HBIO - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Harvard Bioscience|HBIO - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Harvard Bioscience|HBIO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan harvardbioscience.com|HBIO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Harvard Bioscience
Analisis fundamental perusahaan:HBIO, Harvard Bioscience
Conservative capital demands maximum transparency in assessing future cash flows and earnings sustainability. This indicator tracks the trend of the consensus forecast for earnings per share growth rates, signaling valuation revisions by investment houses and the risk of overpayment at extreme values. For Harvard Bioscience (HBIO), this is critical, as the expected EPS change for the coming year reflects the effectiveness of cost optimization amid a cyclical capex downturn in the laboratory sector.
Perusahaan pesaing
Prakiraan wutah bathi resik saben saham kanggo taun ngarep Intuitive Surgical Inc|Danaher Corporation Inc. (DHR) - Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep BDX (Becton Dickinson & Co)|Proyeksi tambahing bathi saben saham ing taun ngarep STE|Prakiraan wutah bathi resik saben saham kanggo taun ngarep West Pharmaceutical Services, Inc. WST|Dinamika bathi saben saham sing diarepake ing taun ngarep BAX|MASI: Prakiraan wutah bathi saben saham kanggo taun ngarep|STVN - Prakiraan wutah bathi kanggo taun ngarep|Teleflex Incorporated (TFX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep merit.com|NVST (Envista) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep ICU Medical Inc ICUI|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Dentsply (XRAY)|LeMaitre Corp - Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep|AtriCure, Inc. - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep STAA (staar.com)|NAGE - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep ZimVie Inc ZIMV|ANGO: Prakiraan wutah bathi kanggo taun ngarep|Cerus Inc - Dinamika bathi saben saham sing diarepake ing taun ngarep|TKNO (Alpha Teknova, Inc.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi kanggo taun ngarep monogramorthopedics.com|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Sharps Technology, Inc. (STSS)|INFU (infusystem.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Utah Medical - Prakiraan wutah bathi saben saham kanggo taun ngarep|KORU Medical Systems, Inc. - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Nyxoah S.A. - Prakiraan wutah bathi kanggo taun ngarep|MBOT - Prakiraan wutah bathi kanggo taun ngarep|Pro-Dex (PDEX) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Zentek Ltd - Dinamika bathi saben saham sing diarepake ing taun ngarep|ELUT (Elutia Corp) - Prakiraan wutah bathi kanggo taun ngarep|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep MLSS (Milestone Scientific Corporation)|Prakiraan wutah bathi saben saham kanggo taun ngarep NXGL (NEXGEL, Inc.)|RVP (retractable.com) - Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep FEMY (Femasys)|Meihua Medical Technologies - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Predictive Oncology Corp - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Callan JMB Inc CJMB|Atrion Corporation (ATRI) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep neurometrix.com (NURO)
